4//SEC Filing
Burke Steven Keith 4
Accession 0001562180-22-006402
CIK 0001517022other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:15 PM ET
Size
5.1 KB
Accession
0001562180-22-006402
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2022-08-31$0.36/sh−1,147$416→ 418,016 total
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019.
- [F2]Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2022, under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001619834
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 4:15 PM ET
- Size
- 5.1 KB